[1]
“Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Mongolian Patients with Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the SIRveNIB Study”, Cent Asian J Med Sci, vol. 5, no. 3, pp. 188–196, Sep. 2019, doi: 10.24079/cajms.2019.09.005.